Lao People's Democratic Republic vs Nigeria: Treatment success rate for patients treated for MDR-TB
Lao People's Democratic Republic
76.0%
in 2022
Nigeria
76.0%
in 2022
Lao People's Democratic Republic rank
64th
Nigeria rank
64th
Treatment success rate for patients treated for MDR-TB over time
- Lao People's Democratic Republic
- Nigeria
How they compare
Lao People's Democratic Republic currently reports 76.0% against 76.0% in Nigeria, a difference of 0.0%.
The two have swapped places 5 times across 12 shared years of data; in 2011 it was Lao People's Democratic Republic ahead.
Lao People's Democratic Republic ranks 64th and Nigeria ranks 64th of 163 countries.
Nigeria has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Lao People's Democratic Republic | Nigeria | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 73.1% | 74.0% | 0.9% | Nigeria |
| 2020s | 78.0% | 81.0% | 3.0% | Nigeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Lao People's Democratic Republic or Nigeria?
- Lao People's Democratic Republic, at 76.0% against 76.0% in Nigeria as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Lao People's Democratic Republic and Nigeria?
- 0.0%, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Lao People's Democratic Republic and Nigeria?
- 12 years are reported by both, from 2011 to 2022.
- How do Lao People's Democratic Republic and Nigeria rank globally for treatment success rate for patients treated for mdr-tb?
- Lao People's Democratic Republic ranks 64th and Nigeria ranks 64th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.